The purpose of the test is to quickly stratify patients with massive traumatic injuries by who will truly benefit from a blood transfusion, and those who do not require it: using a portable new instrument.
The development path included forming a collaborative interaction with a facilitation infrastructure organisation - National Institute for Health Research (NIHR) that has enabled HBL access to leading clinical researchers, front-line health-care professionals including clinicians and nurses, patient and public involvement and (PPI/E), NICE, and commissioners. HBL has been able to establish a clear plan to demonstrate the clinical value of the technology and demonstrate the potential for adoption into the NHS and beyond.
A protocol was developed and ethics approval received. The pilot trial was completed with 25 blood samples from “code red” patients who are already being tested for coagulopathy laboratory instrument.
The CoaguScan device is designed to guide clinicians to how which drugs and blood products that the patient will benefit the most from.
Mr. Mansoor Khan, Consultant Military And Trauma Surgeon with the Trust said:
“We are confident this device which has been through the first trial phase known as the proof of concept phase at St Mary’s Hospital recently, will ultimately help us to save more lives in the future.
“Not only does this allow a clinician to know instantly whether a patient requires a blood transfusion or not, which using current methods takes up to one hour to determine – it also allows clinicians to move away from the one size fits all approach when it comes to blood transfusions for patients with severe bleeding."
After the proof of concept trial, the results demonstrated the portable technology was able to identify patients in the same way as a large and heavy laboratory instrument.
In conclusion to a recent NIHR study “CoaguScan appears to be a “game changer” which could bring more reliable results. The device could be easily adapted to different pathways, extending its potential market